These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 32550040)
1. Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019. Liu MY; Zheng B; Zhang Y; Li JP Chronic Dis Transl Med; 2020 Jun; 6(2):98-105. PubMed ID: 32550040 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway. Felber R; New W; Riskin SI Cureus; 2024 Mar; 16(3):e55563. PubMed ID: 38576704 [TBL] [Abstract][Full Text] [Related]
3. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Kai H; Kai M Hypertens Res; 2020 Jul; 43(7):648-654. PubMed ID: 32341442 [TBL] [Abstract][Full Text] [Related]
4. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2. Young MJ; Clyne CD; Chapman KE J Endocrinol; 2020 Nov; 247(2):R45-R62. PubMed ID: 32966970 [TBL] [Abstract][Full Text] [Related]
5. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities. Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
7. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110 [TBL] [Abstract][Full Text] [Related]
8. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance. Melissa Hallow K; Dave I Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503 [TBL] [Abstract][Full Text] [Related]
9. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019. Zheng H; Cao JJ Am J Pathol; 2020 Oct; 190(10):2013-2017. PubMed ID: 32735889 [TBL] [Abstract][Full Text] [Related]
11. Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury. Ventura D; Carr AL; Davis RD; Silvestry S; Bogar L; Raval N; Gries C; Hayes JE; Oliveira E; Sniffen J; Allison SL; Herrera V; Jennings DL; Page RL; McDyer JF; Ensor CR Open Forum Infect Dis; 2021 Oct; 8(10):ofab170. PubMed ID: 34642634 [TBL] [Abstract][Full Text] [Related]
12. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598 [TBL] [Abstract][Full Text] [Related]
13. Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection. Paul D; Mohankumar SK; Thomas RS; Kheng CB; Basavan D Curr Drug Targets; 2022; 23(4):364-372. PubMed ID: 34732115 [TBL] [Abstract][Full Text] [Related]
14. The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Bosso M; Thanaraj TA; Abu-Farha M; Alanbaei M; Abubaker J; Al-Mulla F Mol Ther Methods Clin Dev; 2020 Sep; 18():321-327. PubMed ID: 32665962 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500 [TBL] [Abstract][Full Text] [Related]
16. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019. Coto E; Avanzas P; Gómez J Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961 [TBL] [Abstract][Full Text] [Related]
17. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2. Elrashdy F; Redwan EM; Uversky VN Infect Genet Evol; 2020 Nov; 85():104510. PubMed ID: 32853823 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019. Siri-Angkul N; Chattipakorn SC; Chattipakorn N J Physiol; 2020 Oct; 598(19):4181-4195. PubMed ID: 32710575 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]